ipamorelin wiki (Ipamorelin, NNC 26-0161, GHS-R1a agonist) · Mechanism, Evidence, FAQ · PEPPUDEX Peptide Therapy - Ipamorelin –

Growth hormone peptides represent one of the more clinically interesting tools in modern metabolic medicine for addressing this decline

K., Teichman, S

Growth Hormone Release Moderate Research Research demonstrates significant, dose-dependent increases in growth hormone levels following Ipamorelin administration (PMID: 9849822), with peak GH concentrations occurring approximately 30-40 minutes post-injection (PMID: 10496658)

When stimulated simultaneously, the two receptors produce a synergistic GH pulse that substantially exceeds what either compound generates alone an effect documented in the broader GHRH + GHRP literature going back to the 1990s